Quebecor, Inc. (TSE:QBR.B – Get Rating) has received a consensus rating of “Buy” from the eight analysts that are covering the stock, Marketbeat Ratings reports. Five research analysts have rated the stock with a buy recommendation. The average 12-month target price among brokerages that have issued a report on the stock in the last year is C$34.66.
Several equities analysts have recently issued reports on the stock. Scotiabank boosted their price target on shares of Quebecor from C$32.00 to C$32.25 in a report on Tuesday, September 6th. National Bankshares raised shares of Quebecor to a “buy” rating and set a C$32.00 price objective for the company in a report on Sunday, June 19th. Royal Bank of Canada upped their price objective on shares of Quebecor from C$35.00 to C$36.00 and gave the stock an “outperform” rating in a report on Friday, August 5th. Finally, TD Securities upped their price objective on shares of Quebecor from C$36.00 to C$40.00 and gave the stock a “buy” rating in a report on Friday, August 5th.
Quebecor Stock Performance
Shares of QBR.B opened at C$26.86 on Friday. Quebecor has a 1 year low of C$26.03 and a 1 year high of C$32.72. The company has a market cap of C$6.26 billion and a price-to-earnings ratio of 10.83. The company has a debt-to-equity ratio of 453.23, a quick ratio of 0.35 and a current ratio of 0.70. The firm has a fifty day moving average of C$28.27 and a 200-day moving average of C$28.88.
Quebecor Company Profile
Quebecor Inc operates in the telecommunications, media, and sports and entertainment businesses in Canada. Its Telecommunications segment offers television distribution, Internet access, business solutions, cable and mobile telephony, and over-the-top video services; and engages in the rental of movies, televisual products, and video games through its video-on-demand service and video rental stores.
- Tax Credits are the Incentives in the Inflation Reduction Act
- 3 Banks Worth Considering For Q4
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- MarketBeat: Week in Review 9/12 – 9/16
- Is There a Cure for What is Ailing Teladoc Stock?
Receive News & Ratings for Quebecor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quebecor and related companies with MarketBeat.com's FREE daily email newsletter.